CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.
about
Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsThe chemokine superfamily revisitedDeregulation of type I IFN-dependent genes correlates with increased susceptibility to cytomegalovirus acute infection of dicer mutant miceThe CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the HeartEpithelial expression of interleukin-37b in inflammatory bowel diseaseCytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide TherapyMacrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans.A simple method to quantitate IP-10 in dried blood and plasma spotsEffect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosisSalmonella Suppresses the TRIF-Dependent Type I Interferon Response in Macrophages.Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines.Elevated OPN, IP-10, and neutrophilia in loop-mediated isothermal amplification confirmed tuberculosis patients.Seasonal and pandemic influenza H1N1 viruses induce differential expression of SOCS-1 and RIG-I genes and cytokine/chemokine production in macrophages.CCL2/MCP-I genotype-phenotype relationship in latent tuberculosis infectionBaicalin downregulates Porphyromonas gingivalis lipopolysaccharide-upregulated IL-6 and IL-8 expression in human oral keratinocytes by negative regulation of TLR signaling.Serum inflammatory mediators as markers of human Lyme disease activity.Recall T cell responses to bluetongue virus produce a narrowing of the T cell repertoireElevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.Plasma IP-10 Concentrations Correlate Positively with Viraemia and Inversely with CD4 Counts in Untreated HIV InfectionThe role of CXCL10 in the pathogenesis of experimental septic shockCXCL10 and IL-6: Markers of two different forms of intra-amniotic inflammation in preterm labor.Lipopolysaccharide-Induced Profiles of Cytokine, Chemokine, and Growth Factors Produced by Human Decidual Cells Are Altered by Lactobacillus rhamnosus GR-1 Supernatant.The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease.Dendritic cells from aged subjects display enhanced inflammatory responses to Chlamydophila pneumoniae.Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patternsAnnexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replicationExpression sequence tag library derived from peripheral blood mononuclear cells of the chlorocebus sabaeus.Transcriptome profiling of CTLs regulated by rapamycin using RNA-SeqIP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection.Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.High IP-10 levels decrease T cell function in HIV-1-infected individuals on ARTInflammatory Markers of the Systemic Capillary Leak Syndrome (Clarkson Disease).TRIF is required for TLR4 mediated adjuvant effects on T cell clonal expansion.Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice.Porphyromonas gingivalis downregulates the immune response of fibroblasts.Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophagesProtection from systemic Candida albicans infection by inactivation of the Sts phosphatasesRole of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease.IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection.A novel host-proteome signature for distinguishing between acute bacterial and viral infections.
P2860
Q26800158-5DD3C8F0-6B68-4CE8-8EEB-58585C4937E0Q26824492-29FF99BC-6065-453A-9A6A-9EE402B08EC8Q27322501-C4AC554F-BB7C-47AB-83D0-A7DDF1EC3B7CQ28079006-1242AAB5-B72A-4747-9E37-4FF7E326200BQ28397770-5B8A3B1A-1BD7-4E00-B94A-5847FF178274Q28545824-A83C78D3-B349-4D02-B36A-02EB8A00AD69Q28588761-F52B35CF-0A1C-4550-939F-6C6514DF2DBCQ28727912-CF817A53-B27E-4DF9-B1A3-FAA37FD886D1Q28729980-B953B5A0-9066-4F3B-A0CD-EC25BF5D8F1DQ30277329-59AC4CFD-4D06-4A48-B462-A17F9CA86567Q30367153-04CADEF5-F15F-4678-9F7D-6B380AD844ADQ30390343-A424033F-F70B-41F5-8B23-5A96DC91F248Q30427498-5C570EDF-AA85-4A65-AF2F-3D073255F59AQ31032605-5275AB79-2862-4824-8A29-FA12DB90AE24Q31109214-6B42DB91-D79A-45C2-BE02-E1F096AB2113Q31158874-F1AF0B57-A2E0-4271-BE45-8DF86F0B66FFQ32178442-0832D9FB-EBAA-4C45-A66C-752EDE7A505BQ33439399-9CA95E83-2611-4AF8-8710-FCC4AFD7D85AQ33668482-A6E86042-53ED-4379-A5CB-A5399BBF968AQ33821851-EB4C2E17-FEC9-4CD4-9E8F-357BB129AC1DQ33845963-98553DB2-A4D9-421B-B151-4EB5FC34EAB3Q33936684-5DA31E7B-E590-4279-9E2F-CA1FF2956411Q34119277-09B1A39D-7879-46AA-BC97-8974D05AD8C1Q34196193-915F9102-0410-4E6B-85A0-E56F06CB5C64Q34261565-ABDF81D1-11E8-4CA7-8D88-791880A6AB40Q34261979-BA73A32F-1900-488E-934D-A741E8747FEAQ34315105-7C61772D-420E-44AB-8979-F8376AFEB2A6Q34345253-484E2EF1-A4FB-442A-A39D-B47A036DF601Q34425282-17453FBD-4B01-4CC7-86A9-182E86949A81Q34457611-155AF112-C868-4223-9DD6-58847B1A23D8Q34484092-A92D21B4-A486-4913-B454-0149DAC62C04Q34516755-101D8FAD-BBB5-40A5-9958-CC5C2B4156E6Q34607160-FCA7FC75-71E9-4977-A095-B746174EF5A8Q34749424-9FB94886-A8C6-4008-8B8A-89EAC2BE7539Q34809679-D7B0F650-DCB5-4344-9448-0F764F19A6D9Q34847755-D8EBEEB4-5BFB-4A20-9177-2A9454DC6314Q34955565-FDE96642-8289-4CC1-AA40-F6F48E23C348Q35106620-93ADB6DC-6AFA-4E0B-A03C-5277EC350A23Q35188912-D7C546F5-6F7E-4B15-A86B-4C342FDFF904Q35192422-4105C478-8D20-49D7-968E-B5A54EDE3E4E
P2860
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.
@ast
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.
@en
type
label
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.
@ast
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.
@en
prefLabel
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.
@ast
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.
@en
P2093
P2860
P50
P1476
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.
@en
P2093
Mingli Liu
Neeru Singh
Shanchun Guo
Vidhan Jain
P2860
P304
P356
10.1016/J.CYTOGFR.2011.06.001
P577
2011-06-01T00:00:00Z